interleukin

(redirected from Interleukin-13)
Also found in: Thesaurus, Medical, Encyclopedia.

in·ter·leu·kin

 (ĭn′tər-lo͞o′kĭn)
n.
Any of various small proteins that are produced by a variety of cell types, especially T cells and other white blood cells, and that regulate many aspects of inflammation and the immune response, including stimulating the production of white blood cells and platelets.

interleukin

(ˌɪntəˈluːkɪn)
n
(Biochemistry) a substance extracted from white blood cells that stimulates their activity against infection and may be used to combat some forms of cancer

in•ter•leu•kin

(ˈɪn tərˌlu kɪn)
n.
any of a family of small proteins that participate in the body's defense system, esp. by promoting the growth and activation of white blood cells.
[1979; inter- + leuk (ocyte) + -in1; so called because such proteins act as agents of communication between different populations of leukocytes]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.interleukin - any of several lymphokines that promote macrophages and killer T cells and B cells and other components of the immune system
lymphokine - a cytokine secreted by helper T cells in response to stimulation by antigens and that acts on other cells of the immune system (as by activating macrophages)
References in periodicals archive ?
Dupixent is a fully-human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) proteins.
The company added Dupixent is a fully-human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) proteins.
Dupixent is a fully-human monoclonal antibody that inhibits the signaling of interleukin-4 (IL-4) and interleukin-13 (IL-13), two proteins that play a central role in type 2 inflammation.
Dupixent is a fully-human monoclonal antibody that inhibits the signaling of interleukin-4 and interleukin-13, two proteins that play a central role in type 2 inflammation.
Dupilumab (Dupixent), a monoclonal antibody that inhibits signaling of both interleukin-4 and interleukin-13, approved in 2017 for adults with moderate to severe AD, has been a "game changer" for this population, Dr.
Keywords: Pre-diabetes, Tuberculosis, Interleukin-13, Diabetes, Interferon-gamma.
"Treatments targeting cytokines, such as interleukin-4 and interleukin-13, have been shown to decrease symptoms of depression and anxiety in patients with atopic dermatitis."
Likewise, expression of interleukin-13 receptor subunit alpha-2 (IL-13RA2) has been demonstrated to increase in peripheral blood mononuclear cells (PBMC) of obese children with abnormal insulin sensitivity as compared to normal weight boys [25].
Ahn et al., "Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles," American Journal of Respiratory Cell and Molecular Biology, vol.
The effects of vitamin D on allergen-induced expression of interleukin-13 and interleukin-17 in cord blood [CD4.sup.+] T cells.
In the CHRONOS study of adults with uncontrolled, moderate to severe AD, patients were treated with the investigational biologic dupilumab (Dupixent), an interleukin-4 and interleukin-13 pathway blocker administered in subcutaneous injections, in combination with topical corticosteroids.
The new drug works by blocking two proteins linked to inflammation, interleukin-4 (IL-4) and interleukin-13 (IL-13).